The role of ERBB4 in cancer progression, including breast cancer, is currently controversial since both tumor suppressive and oncogenic activities for ERBB4 have been documented [reviewed in (13, 21, 49)]. This evidence concerns the gene ERBB4 and breast carcinoma.